NCX 470 advances toward US, China NDA submissions for NCX 470 | Optometry Times - Clinical News

Published on December 20, 2025
NCX 470 is Nicox’s lead dual-mechanism bimatoprost eye drop for lowering IOP in open-angle glaucoma or ocular hypertension.
Continue reading on website
Other news

Unmet Needs in Dry Eye Disease | Optometry Times - Clinical News

December 18, 2025

Artisan Lab Network Hosts First PAL Shareholder Conference

December 21, 2025
DENVER—Artisan Lab Network (ALN), a doctor-owned network of ophthalmic laboratories, recently convened equity members from its partner laboratories for the first-ever PAL Shareholder Conference, the company announced.